Vitalhub Corp. (TSE:VHI - Get Free Report)'s share price hit a new 52-week high on Wednesday . The stock traded as high as C$12.76 and last traded at C$12.73, with a volume of 34112 shares changing hands. The stock had previously closed at C$12.53.
Analyst Ratings Changes
Several analysts have weighed in on the company. TD Securities lifted their target price on Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research note on Monday, March 31st. National Bankshares set a C$14.00 target price on Vitalhub and gave the company an "outperform" rating in a research note on Tuesday, June 10th. Raymond James Financial lifted their price target on Vitalhub from C$13.50 to C$14.00 and gave the company an "outperform" rating in a research report on Friday, June 20th. National Bank Financial upgraded Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. Finally, Scotiabank lifted their price target on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research report on Friday, June 20th. Six analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Vitalhub has an average rating of "Buy" and a consensus target price of C$13.25.
Get Our Latest Report on VHI
Vitalhub Price Performance
The firm has a market cap of C$714.56 million, a PE ratio of 214.86, a P/E/G ratio of 1.18 and a beta of 1.26. The business has a fifty day moving average price of C$11.17 and a two-hundred day moving average price of C$10.71.
Insider Transactions at Vitalhub
In other news, Director Francis Nelson Shen acquired 25,000 shares of Vitalhub stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of C$10.23 per share, with a total value of C$255,750.00. Insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.